Global trial expansion: Navigating Australia & LATAM's evolving clinical research landscape
Accelerate your global clinical strategy
Check out our exclusive webinar where Parexel's regional experts reveal how sponsors can strategically incorporate Australia and Latin America into their global clinical trial portfolio. From Australia's renowned fast-track pathways and generous R&D tax incentives to Latin America's transforming regulatory landscape, this session delivers actionable insights on navigating regulatory pathways, maximizing cost efficiencies, and optimizing patient recruitment across these high-potential regions.
Why watch:
- Strategic advantage: Discover Australia's competitive edge with streamlined regulatory processes and substantial R&D tax incentives
- Regulatory navigation: Master the evolving frameworks across Brazil, Mexico, and Argentina with expert guidance
- Recruitment excellence: Implement proven strategies for optimal site selection and enhanced patient access
- Accelerated pathways: Deploy submission strategies precisely calibrated to regional requirements and expedited approval channels
- Case studies: Explore case studies showing implementation success in these regions
Drawing on Parexel's extensive regional expertise, our specialists equip you with concrete strategies to seamlessly integrate these valuable markets into your global clinical development portfolio—delivering faster start-up times, significant cost efficiencies, and enhanced patient recruitment.
Related Insights
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Article
Decentralized trial tools and technologies are here to stay: A regulatory perspective
Jul 23, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct
Sep 14, 2021
Whitepaper
Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)
Sep 19, 2023
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Related Insights
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Article
Decentralized trial tools and technologies are here to stay: A regulatory perspective
Jul 23, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct
Sep 14, 2021
Whitepaper
Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)
Sep 19, 2023
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023